ISSN: 0163-7258
Journal Home
Journal Guideline
Pharmacology and Therapeutics Q1 Unclaimed
Pharmacology and Therapeutics is a journal indexed in SJR in Pharmacology and Pharmacology (medical) with an H index of 193. It has an SJR impact factor of 3,348 and it has a best quartile of Q1. It is published in English.
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy:
Type of publications:
Publication frecuency: -
- €
Gold OA-
Green OA- €
Non OAMetrics
3,348
SJR Impact factor193
H Index149
Total Docs (Last Year)433
Total Docs (3 years)32417
Total Refs4427
Total Cites (3 years)433
Citable Docs (3 years)10,31
Cites/Doc (2 years)217,56
Ref/DocAims and Scope
Best articles
5-Hydroxytryptamine2-Family Receptors (5-Hydroxytryptamine2A, 5-Hydroxytryptamine2B, 5-Hydroxytryptamine2C) Where Structure Meets Function
View morea2-Adrenoceptors and I2 sites in the mammalian central nervous system
View moreAccidental hypothermia
View moreAdvances in nonhuman primate alcohol abuse and alcoholism research
View moreAdverse effects of established and new antiepileptic drugs: An attempted comparison
View moreAnaesthetic drugs in the elderly
View moreAnalogs of alkyllysophospholipids: Chemistry, effects on the molecular level and their consequences for normal and malignant cells
View moreAntimalarial activity of synthetic analogues of distamycin
View moreAntitoxic immunity in cholera and enterotoxigenic escherichia coli (ETEC) diarrhea
View moreArtemisinin and its derivatives: an important new class of antimalarial agents
View moreAspects of calcium-activated chloride currents: A neuronal perspective
View moreAstroglial neurotrophic and neurite-promoting factors
View moreBiological rhythms in the inflammatory response and in the effects of non-steroidal anti-inflammatory drugs
View moreCaged Regulators of Signaling Pathways
View moreChemotaxis in Bacillus subtilis: How bacteria monitor environmental signals
View moreClinical benefits and pharmacology of scutellarin: A comprehensive review
View moreClinical pharmacokinetics of new antiepileptic drugs
View moreCyclic GMP-Dependent Protein KinasesUnderstanding in Vivo Functions by Gene Targeting
View moreCytochrome P450-catalyzed pathways in human brain: Metabolism meets pharmacology or old drugs with new mechanism of action?
View moreDrug targeting via retrometabolic approaches
View moreEthanol regulation of gamma-aminobutyric acidA receptors: genomic and nongenomic mechanisms
View moreFactors influencing the metabolism of Diazepam
View moreGABAA receptor subtypes as targets for neuropsychiatric drug development
View moreGenetic variants in major depressive disorder: From pathophysiology to therapy
View more
Comments